source name	characteristics[organism]	characteristics[organism part]	characteristics[cell type]	characteristics[ancestry category]	characteristics[age]	characteristics[sex]	characteristics[disease]	characteristics[individual]	characteristics[timepoint]	assay name	Technology Type	comment[data file]	comment[associated file uri]	comment[fraction identifier]	comment[label]	comment[instrument]	comment[cleavage agent details]	comment[dissociation method]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	factor value[phenotype]
Sample1	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K8	3	Run1	proteomic profiling by mass spectrometry	K8.3QEXI16163.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K8.3QEXI16163.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001251	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample1	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K8	2	Run2	proteomic profiling by mass spectrometry	K8.2QEXI16183.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K8.2QEXI16183.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001252	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample1	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K8	1	Run3	proteomic profiling by mass spectrometry	K8.1QEXI16193.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K8.1QEXI16193.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001253	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample2	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K5	3	Run4	proteomic profiling by mass spectrometry	K5.3QEXI16231.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K5.3QEXI16231.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001254	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample2	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K5	2	Run5	proteomic profiling by mass spectrometry	K5.2QEXI16155.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K5.2QEXI16155.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001255	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample2	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K5	1	Run6	proteomic profiling by mass spectrometry	K5.1QEXI16165.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K5.1QEXI16165.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001256	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample3	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K40	3	Run7	proteomic profiling by mass spectrometry	K40.3QEXI16167.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K40.3QEXI16167.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001257	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample3	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K40	2	Run8	proteomic profiling by mass spectrometry	K40.2QEXI16217.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K40.2QEXI16217.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001258	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample3	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K40	1	Run9	proteomic profiling by mass spectrometry	K40.1QEXI16227.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K40.1QEXI16227.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001259	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample4	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K39	3	Run10	proteomic profiling by mass spectrometry	K39.3QEXI16213.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K39.3QEXI16213.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001260	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample4	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K39	2	Run11	proteomic profiling by mass spectrometry	K39.2QEXI16229.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K39.2QEXI16229.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001261	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample4	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K39	1	Run12	proteomic profiling by mass spectrometry	K39.1QEXI16181.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K39.1QEXI16181.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001262	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample5	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K38	3	Run13	proteomic profiling by mass spectrometry	K38.3QEXI16219.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K38.3QEXI16219.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001263	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample5	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K38	2	Run14	proteomic profiling by mass spectrometry	K38.2QEXI16211.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K38.2QEXI16211.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001264	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample5	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K38	1	Run15	proteomic profiling by mass spectrometry	K38.1QEXI16199.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K38.1QEXI16199.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001265	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample6	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K36	3	Run16	proteomic profiling by mass spectrometry	K36.3QEXI16185.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K36.3QEXI16185.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001266	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample6	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K36	2	Run17	proteomic profiling by mass spectrometry	K36.2QEXI16167.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K36.2QEXI16167.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001267	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample6	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K36	1	Run18	proteomic profiling by mass spectrometry	K36.1QEXI16221.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K36.1QEXI16221.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001268	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample7	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K33	3	Run19	proteomic profiling by mass spectrometry	K33.3QEXI16157.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K33.3QEXI16157.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001269	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample7	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K33	2	Run20	proteomic profiling by mass spectrometry	K33.2QEXI16189.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K33.2QEXI16189.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001270	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample7	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K33	1	Run21	proteomic profiling by mass spectrometry	K33.1QEXI16215.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K33.1QEXI16215.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001271	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample8	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K26	3	Run22	proteomic profiling by mass spectrometry	K26.3QEXI16197.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K26.3QEXI16197.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001272	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample8	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K26	2	Run23	proteomic profiling by mass spectrometry	K26.2QEXI16223.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K26.2QEXI16223.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001273	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample8	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K26	1	Run24	proteomic profiling by mass spectrometry	K26.1QEXI16171.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K26.1QEXI16171.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001274	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample9	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K2	3	Run25	proteomic profiling by mass spectrometry	K2.3QEXI16191.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K2.3QEXI16191.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001275	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample9	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K2	2	Run26	proteomic profiling by mass spectrometry	K2.2QEXI16173.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K2.2QEXI16173.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001276	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample9	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K2	1	Run27	proteomic profiling by mass spectrometry	K2.1QEXI16159.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K2.1QEXI16159.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001277	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample10	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K14	3	Run28	proteomic profiling by mass spectrometry	K14.3QEXI16175.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K14.3QEXI16175.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001278	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample10	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K14	2	Run29	proteomic profiling by mass spectrometry	K14.2QEXI16161.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K14.2QEXI16161.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001279	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample10	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K14	1	Run30	proteomic profiling by mass spectrometry	K14.1QEXI16209.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K14.1QEXI16209.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001280	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample11	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K13	3	Run31	proteomic profiling by mass spectrometry	K13.3QEXI16225.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K13.3QEXI16225.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001281	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample11	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K13	2	Run32	proteomic profiling by mass spectrometry	K13.2QEXI16201.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K13.2QEXI16201.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001282	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample11	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K13	1	Run33	proteomic profiling by mass spectrometry	K13.1QEXI16187.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K13.1QEXI16187.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001283	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample12	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K1	3	Run34	proteomic profiling by mass spectrometry	K1.3QEXI16203.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K1.3QEXI16203.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001284	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample12	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K1	2	Run35	proteomic profiling by mass spectrometry	K1.2QEXI16195.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K1.2QEXI16195.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001285	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
Sample12	homo sapiens	NT=cerebrospinal fluid; AC=UBERON:0001359	not applicable	not available	anonymized	anonymized	NT = healthy; AC = HP:0032322	K1	1	Run36	proteomic profiling by mass spectrometry	K1.1QEXI16153.raw	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2019/11/PXD007555/K1.1QEXI16153.raw	1	NT=label free sample; AC=MS:1002038	NT=Q Exactive; AC = MS:1001911	NT=Trypsin;AC=MS:1001286	NT=HCD; AC = PRIDE:0000590	5 ppm	20 ppm	NT=Carbamidomethyl; MT=fixed; PP=Anywhere; AC=Unimod:4; TA=C; MM= 57.021464; CF=H(3)C(2)NO	NT=Oxidation; MT=variable; PP=Anywhere; AC=Unimod:35; TA=M; MM= 15.994915; CF=O	NT=Acetylation; MT=variable; PP=Protein N-Term; AC=Unimod:1; TA=.; MM= 42.010565; CF=H(2)C(2)O	healthy control
